Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson's Disease by Oral Administration of Ether Phospholipids: A Preliminary Report

Introduction. Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease (AD). With the ageing of population, the frequency of PD is expected to increase dramatically in the coming decades. L-DOPA (1,3,4-dihydroxyalanine) is the most effective dr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Parkinsons Dis
Asıl Yazarlar: Mawatari, Shiro, Ohara, Shinji, Taniwaki, Yoshihide, Tsuboi, Yoshio, Maruyama, Toru, Fujino, Takehiko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049862/
https://ncbi.nlm.nih.gov/pubmed/32148751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2671070
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller